Aleukemic congenital leukemia cutis preceding monocytic leukemia with favorable outcome: A case report

Autor: Caroline Lo Presti, Gautier Szymanski, Christine Lefebvre, Marie‐Christine Jacob, Pascal Mossuz, Hugo Gil

Publikováno v: eJHaem, Vol 5, Iss 1, Pp 162-165 (2024)

Abstract A newborn girl had typical “blueberry muffin” skin lesions, which shows histopathologic features of monocytic leukemia cutis. The systemic leukemia was demonstrated after one month of life. She was treated by chemotherapy, including indu

Externí odkaz: https://doaj.org/article/acf34bdb20e64adb8f35fef8ed25dbfc

Diagnosis of acute promyelocytic leukemia based on routine biological parameters using machine learning

Autor: Estelle Cheli, Simon Chevalier, Olivier Kosmider, Marion Eveillard, Nicolas Chapuis, Adriana Plesa, Maël Heiblig, Lydie Andre, Jenny Pouget, Pascal Mossuz, Olivier Theisen, Vincent Alcazer, Dan Gugenheim, Nicolas Autexier, Pierre Sujobert

Publikováno v: Haematologica, Vol 107, Iss 6 (2022)

Externí odkaz: https://doaj.org/article/a56a236ea53f4b179aef15a9d5b17f7b

Data from Quantitative Proteome Heterogeneity in Myeloproliferative Neoplasm Subtypes and Association with JAK2 Mutation Status

Autor: Pascal Mossuz, Isabelle Plo, Julie Mondet, Vladan P. Čokić, Nuria Socoro-Yuste

Apart from well-known genetic abnormalities, several studies have reported variations in protein expression in Philadelphia-negative myeloproliferative neoplasm (MPN) patients that could contribute toward their clinical phenotype. In this context, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::af4d0f1b3900cbb9219a31272a6ad733
https://doi.org/10.1158/1541-7786.c.6539994.v1

Pathogenic Roles of S100A8 and S100A9 Proteins in Acute Myeloid and Lymphoid Leukemia: Clinical and Therapeutic Impacts

Autor: Julie Mondet, Simon Chevalier, Pascal Mossuz

Publikováno v: Molecules, Vol 26, Iss 5, p 1323 (2021)

Deregulations of the expression of the S100A8 and S100A9 genes and/or proteins, as well as changes in their plasma levels or their levels of secretion in the bone marrow microenvironment, are frequently observed in acute myeloblastic leukemias (AML)

Externí odkaz: https://doaj.org/article/1703bb636d9245e2b45fd2a717708b41

Evaluation of the human type 3 adenoviral dodecahedron as a vector to target acute myeloid leukemia

Autor: Dominique Plantaz, Dalil Hannani, Jadwiga Chroboczek, Benjamin Caulier, Mélanie Guidetti, Gaëlle Stofleth, Véronique Josserand, David Laurin, Pascal Mossuz

Publikováno v: Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 181-190 (2021)
Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2020, ⟨10.1016/j.omtm.2020.11.009⟩
Molecular Therapy. Methods & Clinical Development

Intensive systemic chemotherapy is the gold standard of acute myeloid leukemia (AML) treatment and is associated with considerable off-target toxicities. Safer and targeted delivery systems are thus urgently needed. In this study, we evaluated a viru

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6efb508e07b9fd77da0853d5040ce25
https://doi.org/10.1016/j.omtm.2020.11.009